<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.parasitesandvectors.com/feeds/mostaccessed/journal?quantity=&amp;format=rss&amp;version=">
        <title>Parasites &amp; Vectors - Most accessed articles</title>
        <link>http://www.parasitesandvectors.com</link>
        <description>The most accessed research articles published by Parasites &amp; Vectors</description>
        <dc:date>2012-01-12T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.parasitesandvectors.com/content/4/1/41" />
                                <rdf:li rdf:resource="http://www.parasitesandvectors.com/content/5/1/6" />
                                <rdf:li rdf:resource="http://www.parasitesandvectors.com/content/3/1/5" />
                                <rdf:li rdf:resource="http://www.parasitesandvectors.com/content/5/1/5" />
                                <rdf:li rdf:resource="http://www.parasitesandvectors.com/content/1/1/3" />
                                <rdf:li rdf:resource="http://www.parasitesandvectors.com/content/5/1/8" />
                                <rdf:li rdf:resource="http://www.parasitesandvectors.com/content/5/1/15" />
                                <rdf:li rdf:resource="http://www.parasitesandvectors.com/content/5/1/11" />
                                <rdf:li rdf:resource="http://www.parasitesandvectors.com/content/4/1/234" />
                                <rdf:li rdf:resource="http://www.parasitesandvectors.com/content/5/1/9" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.parasitesandvectors.com/content/4/1/41">
        <title>Zoonotic helminths affecting the human eye</title>
        <description>Nowaday, zoonoses are an important cause of human parasitic diseases worldwide and a major threat to the socio-economic development, mainly in developing countries. Importantly, zoonotic helminths that affect human eyes (HIE) may cause blindness with severe socio-economic consequences to human communities. These infections include nematodes, cestodes and trematodes, which may be transmitted by vectors (dirofilariasis, onchocerciasis, thelaziasis), food consumption (sparganosis, trichinellosis) and those acquired indirectly from the environment (ascariasis, echinococcosis, fascioliasis). Adult and/or larval stages of HIE may localize into human ocular tissues externally (i.e., lachrymal glands, eyelids, conjunctival sacs) or into the ocular globe (i.e., intravitreous retina, anterior and or posterior chamber) causing symptoms due to the parasitic localization in the eyes or to the immune reaction they elicit in the host. Unfortunately, data on HIE are scant and mostly limited to case reports from different countries. The biology and epidemiology of the most frequently reported HIE are discussed as well as clinical description of the diseases, diagnostic considerations and video clips on their presentation and surgical treatment.Homines amplius oculis, quam auribus creduntSeneca Ep 6,5Men believe their eyes more than their ears</description>
        <link>http://www.parasitesandvectors.com/content/4/1/41</link>
                <dc:creator>Domenico Otranto</dc:creator>
                <dc:creator>Mark Eberhard</dc:creator>
                <dc:source>Parasites &amp; Vectors 2011, null:41</dc:source>
        <dc:date>2011-03-23T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-3305-4-41</dc:identifier>
                                    <dc:description>Zoonotic helminths that affect human eyes may cause blindness with severe socio-economic consequences to human communities. Their biology and epidemiology are discussed as well as clinical descriptions of the diseases, and video clips on their presentation. Image: Coenurus cyst with multiple protoscoleces behind displaced retina. (modified from Orihel and Ash, ASCP Press, 1995).
</dc:description>
                <prism:require>/content/figures/1756-3305-4-41-toc.gif</prism:require>
                <prism:publicationName>Parasites &amp; Vectors</prism:publicationName>
        <prism:issn>1756-3305</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>41</prism:startingPage>
        <prism:publicationDate>2011-03-23T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.parasitesandvectors.com/content/5/1/6">
        <title>Biology and pathogenesis of Acanthamoeba</title>
        <description>Acanthamoeba is a free-living protist pathogen, capable of causing a blinding keratitis and fatal granulomatous encephalitis. The factors that contribute to Acanthamoeba infections include parasite biology, genetic diversity, environmental spread and host susceptibility, and are highlighted together with potential therapeutic and preventative measures. The use of Acanthamoeba in the study of cellular differentiation mechanisms, motility and phagocytosis, bacterial pathogenesis and evolutionary processes makes it an attractive model organism. There is a significant emphasis on Acanthamoeba as a Trojan horse of other microbes including viral, bacterial, protists and yeast pathogens.</description>
        <link>http://www.parasitesandvectors.com/content/5/1/6</link>
                <dc:creator>Ruqaiyyah Siddiqui</dc:creator>
                <dc:creator>Naveed Khan</dc:creator>
                <dc:source>Parasites &amp; Vectors 2012, null:6</dc:source>
        <dc:date>2012-01-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-3305-5-6</dc:identifier>
                                    <dc:description>We describe the current understanding of Acanthamoeba biology, its ability to produce disease and the underlying molecular mechanisms. The use of Acanthamoeba as a model organism to study cellular processes and its role as a Trojan horse of the microbial world is highlighted. Image: Acanthamoeba trophozoite exhibiting phagocytic cups, known as amoebastomes.</dc:description>
                <prism:require>/content/figures/1756-3305-5-6-toc.gif</prism:require>
                <prism:publicationName>Parasites &amp; Vectors</prism:publicationName>
        <prism:issn>1756-3305</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>6</prism:startingPage>
        <prism:publicationDate>2012-01-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.parasitesandvectors.com/content/3/1/5">
        <title>History of the discovery of the malaria parasites and their vectors</title>
        <description>Malaria is caused by infection with protozoan parasites belonging to the genus Plasmodium transmitted by female Anopheles species mosquitoes. Our understanding of the malaria parasites begins in 1880 with the discovery of the parasites in the blood of malaria patients by Alphonse Laveran. The sexual stages in the blood were discovered by William MacCallum in birds infected with a related haematozoan, Haemoproteus columbae, in 1897 and the whole of the transmission cycle in culicine mosquitoes and birds infected with Plasmodium relictum was elucidated by Ronald Ross in 1897. In 1898 the Italian malariologists, Giovanni Battista Grassi, Amico Bignami, Giuseppe Bastianelli, Angelo Celli, Camillo Golgi and Ettore Marchiafava demonstrated conclusively that human malaria was also transmitted by mosquitoes, in this case anophelines. The discovery that malaria parasites developed in the liver before entering the blood stream was made by Henry Shortt and Cyril Garnham in 1948 and the final stage in the life cycle, the presence of dormant stages in the liver, was conclusively demonstrated in 1982 by Wojciech Krotoski. This article traces the main events and stresses the importance of comparative studies in that, apart from the initial discovery of parasites in the blood, every subsequent discovery has been based on studies on non-human malaria parasites and related organisms.</description>
        <link>http://www.parasitesandvectors.com/content/3/1/5</link>
                <dc:creator>Francis Cox</dc:creator>
                <dc:source>Parasites &amp; Vectors 2010, null:5</dc:source>
        <dc:date>2010-02-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-3305-3-5</dc:identifier>
                            <dc:title>History of the discovery of the malaria parasites</dc:title>
                            <dc:description>The story of the history of the malaria parasites and their mosquito vectors is traced from the first discovery of the parasites in 1880 to the present time. Image: Ronald Ross who discovered that malaria parasites were transmitted by mosquitoes.</dc:description>
                <prism:require>/content/figures/1756-3305-3-5-toc.gif</prism:require>
                <prism:publicationName>Parasites &amp; Vectors</prism:publicationName>
        <prism:issn>1756-3305</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>5</prism:startingPage>
        <prism:publicationDate>2010-02-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.parasitesandvectors.com/content/5/1/5">
        <title>Stray dogs as indicators of Toxoplasma gondii distributed in the environment: the first report across an urban-rural gradient in China</title>
        <description>Background:
Toxoplasmosis is an important parasitic zoonosis caused by the protozoan Toxoplasma gondii that is distributed world-wide and infects a variety of hosts. However, the prevalence of T. gondii in the environment (such as soil, water and food) is largely unknown. Due to the technical difficulty in oocyst counting directly, an alternative assay using the serologic status of T. gondii in free-living animals, such as stray or free-living dogs, as an indicator, can be used to evaluate environmental contamination indirectly, as they are exposed to the same risk of infection as humans and other animals.
Results:
In the present study, 231 stray or free-living dogs across an urban-rural gradient were examined to assess the frequency of T. gondii in the environment. Specific antibodies to T. gondii were found in 93 dogs (40.3%) by enzyme-linked immunosorbent assay (ELISA), and no statistically significant differences were observed in seroprevalences of T. gondii between urban dogs (38.7%) and rural dogs (41%) (p &gt; 0.05).
Conclusions:
A high seroprevalence of T. gondii in stray or free-living dogs in the present study indicates that there would be a wide distribution and a constant infection pressure of T. gondii across an urban-rural gradient, and the oocysts of T. gondii in the environment would be an important source of infection for humans and other animals both in urban and rural areas in China.</description>
        <link>http://www.parasitesandvectors.com/content/5/1/5</link>
                <dc:creator>Chao Yan</dc:creator>
                <dc:creator>Lin-lin Fu</dc:creator>
                <dc:creator>Cai-ling Yue</dc:creator>
                <dc:creator>Ren-xian Tang</dc:creator>
                <dc:creator>Yi-sheng Liu</dc:creator>
                <dc:creator>Liang Lv</dc:creator>
                <dc:creator>Na Shi</dc:creator>
                <dc:creator>Ping Zeng</dc:creator>
                <dc:creator>Peng Zhang</dc:creator>
                <dc:creator>Dong-hui Wang</dc:creator>
                <dc:creator>Dong-hui Zhou</dc:creator>
                <dc:creator>Xing-Quan Zhu</dc:creator>
                <dc:creator>Kui-Yang Zheng</dc:creator>
                <dc:source>Parasites &amp; Vectors 2012, null:5</dc:source>
        <dc:date>2012-01-05T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-3305-5-5</dc:identifier>
                                    <dc:description>This study shows Toxoplasma gondii seroprevalences of 38.7% in urban dogs and 41% in rural dogs (P&gt;0.05), respectively, indicating that there might be a wide distribution and a constant infection pressure of T. gondii across an urban-rural gradient in China. Image: Dogs are important reservoirs and sentinels of Toxoplasma gondii in the environment.</dc:description>
                <prism:require>/content/figures/1756-3305-5-5-toc.gif</prism:require>
                <prism:publicationName>Parasites &amp; Vectors</prism:publicationName>
        <prism:issn>1756-3305</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>5</prism:startingPage>
        <prism:publicationDate>2012-01-05T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.parasitesandvectors.com/content/1/1/3">
        <title>The history of African trypanosomiasis</title>
        <description>The prehistory of African trypanosomiasis indicates that the disease may have been an important selective factor in the evolution of hominids. Ancient history and medieval history reveal that African trypanosomiasis affected the lives of people living in sub-Saharan African at all times. Modern history of African trypanosomiasis revolves around the identification of the causative agents and the mode of transmission of the infection, and the development of drugs for treatment and methods for control of the disease. From the recent history of sleeping sickness we can learn that the disease can be controlled but probably not be eradicated. Current history of human African trypanosomiasis has shown that the production of anti-sleeping sickness drugs is not always guaranteed, and therefore, new, better and cheaper drugs are urgently required.</description>
        <link>http://www.parasitesandvectors.com/content/1/1/3</link>
                <dc:creator>Dietmar Steverding</dc:creator>
                <dc:source>Parasites &amp; Vectors 2008, null:3</dc:source>
        <dc:date>2008-02-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-3305-1-3</dc:identifier>
                            <dc:title>History of African trypanosomiasis</dc:title>
                            <dc:description>This review article summarises the history of African trypanosomiasis from prehistory to current developments.  From this history we learn which factors determine, and which measures control, the emergence and the spread of the disease.

Image: Sir David Bruce (1855-1931).  </dc:description>
                <prism:require>/content/figures/1756-3305-1-3-toc.gif</prism:require>
                <prism:publicationName>Parasites &amp; Vectors</prism:publicationName>
        <prism:issn>1756-3305</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2008-02-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.parasitesandvectors.com/content/5/1/8">
        <title>Changes in the geographical distribution and abundance of the tick Ixodes ricinus during the past 30 years in Sweden </title>
        <description>Background:
Ixodes ricinus is the main vector in Europe of human-pathogenic Lyme borreliosis (LB) spirochaetes, the tick-borne encephalitis virus (TBEV) and other pathogens of humans and domesticated mammals. The results of a previous 1994 questionnaire, directed at people living in Central and North Sweden (Svealand and Norrland) and aiming to gather information about tick exposure for humans and domestic animals, suggested that Ixodes ricinus ticks had become more widespread in Central Sweden and the southern part of North Sweden from the early 1980s to the early 1990s. To investigate whether the expansion of the tick&apos;s northern geographical range and the increasing abundance of ticks in Sweden were still occurring we performed in 2009 a follow-up survey 16 years after the initial study.
Methods:
A questionnaire similar to the one used in the 1994 study was published in Swedish newspapers and magazines aimed at dog owners, home owners, and hunters. The questionnaire was published together with a popular science article about the tick&apos;s biology and role as a pathogen vector in Sweden. The magazines were selected to get information from people familiar with ticks and who spend time in areas where ticks might be present.
Results:
Analyses of data from both surveys revealed that during the near 30-year period from the early 1980s to 2008, I. ricinus has expanded its distribution range northwards. In the early 1990s ticks were found in new areas along the northern coastline of the Baltic Sea, while in the 2009 study ticks were reported for the first time from many locations in North Sweden. This included locations as far north as 66degreesN and places in the interior part of North Sweden. During this 16-year period the tick&apos;s range in Sweden was estimated to have increased by 9.9%. Most of the range expansion occurred in North Sweden (north of 60 oN) where the tick&apos;s coverage area doubled from 12.5% in the early 1990s to 26.8% in 2008. Moreover, according to the respondents the abundance of ticks had increased markedly in LB- and TBE-endemic areas in South (Gotaland) and Central Sweden.
Conclusions:
The results suggest that I. ricinus has expanded its range in North Sweden and has become distinctly more abundant in Central and South Sweden during the last three decades.  However, in the northern mountain region I. ricinus is still absent. The increased abundance of the tick can be explained by two main factors: First, the high availability of large numbers of important tick maintenance hosts, i.e., cervids, particularly roe deer (Capreolus capreolus) during the last three decades. Second, a warmer climate with milder winters and a prolonged growing season that permits for greater survival and proliferation over a larger geographical area of both the tick itself and deer. High reproductive potential of roe deer, high tick infestation rate and the tendency of roe deer to disperse great distances may explain the range expansion of I. ricinus and particularly the appearance of new TBEV foci far away from old TBEV-endemic localities. The geographical presence of LB in Sweden corresponds to the distribution of I. ricinus. Thus, LB is now an emerging disease risk in many parts of North Sweden. Unless countermeasures are undertaken to keep the deer populations, particularly C. capreolus and Dama dama, at the relatively low levels that prevailed before the late 1970s - especially in and around urban areas where human population density is high - by e.g. reduced hunting of red fox (Vulpes vulpes) and lynx (Lynx lynx), the incidences of human LB and TBE are expected to continue to be high or even to increase in Sweden in coming decades.</description>
        <link>http://www.parasitesandvectors.com/content/5/1/8</link>
                <dc:creator>Thomas Jaenson</dc:creator>
                <dc:creator>David Jaenson</dc:creator>
                <dc:creator>Lars Eisen</dc:creator>
                <dc:creator>Erik Petersson</dc:creator>
                <dc:creator>Elisabet Lindgren</dc:creator>
                <dc:source>Parasites &amp; Vectors 2012, null:8</dc:source>
        <dc:date>2012-01-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-3305-5-8</dc:identifier>
                                    <dc:description>In Sweden, the tick (Ixodes ricinus) population has drastically expanded during the last 30 years, presumably in response mainly to the milder climate and a large roe deer population. Indirectly, this has resulted in increasing incidences of tick-borne human diseases. Image: The different active stages of the common European tick Ixodes ricinus.</dc:description>
                <prism:require>/content/figures/1756-3305-5-8-toc.gif</prism:require>
                <prism:publicationName>Parasites &amp; Vectors</prism:publicationName>
        <prism:issn>1756-3305</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>8</prism:startingPage>
        <prism:publicationDate>2012-01-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.parasitesandvectors.com/content/5/1/15">
        <title>SYBR Green-based Real-Time PCR targeting kinetoplast DNA can be used to discriminate between the main etiologic agents of Brazilian cutaneous and visceral leishmaniases</title>
        <description>Background:
Leishmaniases control has been hampered by the unavailability of rapid detection methods and the lack of suitable therapeutic and prophylactic measures. Accurate diagnosis, which can distinguish between Leishmania isolates, is essential for conducting appropriate prognosis, therapy and epidemiology. Molecular methods are currently being employed to detect Leishmania infection and categorize the parasites up to genus, complex or species level. Real-time PCR offers several advantages over traditional PCR, including faster processing time, higher sensitivity and decreased contamination risk.
Results:
A SYBR Green real-time PCR targeting the conserved region of kinetoplast DNA minicircles was able to differentiate between Leishmania subgenera. A panel of reference strains representing subgenera Leishmania and Viannia was evaluated by the derivative dissociation curve analyses of the amplified fragment. Distinct values for the average melting temperature were observed, being 78.95 degreesC +/- 0.01 and 77.36 degreesC +/- 0.02 for Leishmania and Viannia, respectively (p&lt;0.05). Using the Neighbor-Joining method and Kimura 2-parameters, the alignment of 12 sequences from the amplified conserved minicircles segment grouped together L. (V.) braziliensis and L. (V.) shawii with a bootstrap value of 100%; while for L. (L.) infantum and L. (L.) amazonensis, two groups were formed with bootstrap values of 100% and 62%, respectively. The lower dissociation temperature observed for the subgenus Viannia amplicons could be due to a lower proportion of guanine/cytosine sites (43.6%) when compared to species from subgenus Leishmania (average of 48.4%). The method was validated with 30 clinical specimens from visceral or cutaneous leishmaniases patients living in Brazil and also with DNA samples from naturally infected Lutzomyia spp. captured in two Brazilian localities.
Conclusions:
For all tested samples, a characteristic amplicon melting profile was evidenced for each Leishmania subgenus, corroborating the data from reference strains. Therefore, the analysis of thermal dissociation curves targeting the conserved kinetoplast DNA minicircles region is able to provide a rapid and reliable method to identify the main etiologic agents of cutaneous and visceral leishmaniases in endemic regions of Brazil.</description>
        <link>http://www.parasitesandvectors.com/content/5/1/15</link>
                <dc:creator>Daniela Pita-Pereira</dc:creator>
                <dc:creator>Rachel Lins</dc:creator>
                <dc:creator>Marcia Oliveira</dc:creator>
                <dc:creator>Rosimar Lima</dc:creator>
                <dc:creator>Bernardo Pereira</dc:creator>
                <dc:creator>Otacilio Moreira</dc:creator>
                <dc:creator>Reginaldo Brazil</dc:creator>
                <dc:creator>Constanca Britto</dc:creator>
                <dc:source>Parasites &amp; Vectors 2012, null:15</dc:source>
        <dc:date>2012-01-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-3305-5-15</dc:identifier>
                                    <dc:description>SYBR Green-based real-time PCR targeting kDNA minicircles can differentiate between Leishmania subgenera through the amplicons dissociation kinetic. This methodology was further validated with human clinical specimens and field sandflies from Brazil.  Image:  Characteristic SYBR Green dissociation curve profiles of kDNA conserved regions amplicons from both Leishmania subgenera.</dc:description>
                <prism:require>/content/figures/1756-3305-5-15-toc.gif</prism:require>
                <prism:publicationName>Parasites &amp; Vectors</prism:publicationName>
        <prism:issn>1756-3305</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>15</prism:startingPage>
        <prism:publicationDate>2012-01-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.parasitesandvectors.com/content/5/1/11">
        <title>A dysflagellar mutant of Leishmania (Viannia) braziliensis isolated from a cutaneous leishmaniasis patient</title>
        <description>Background:
Parasites of the Leishmania genus alternate between the flagellated extracellular promastigote stage and intracellular amastigotes. Here we report the characterization of a Leishmania isolate, obtained from a cutaneous leishmaniasis patient, which presents peculiar morphological features.
Methods:
The parasite was cultured in vitro and characterized morphologically using optical and electron microscopy. Identification was performed based on monoclonal antibodies and internal ribosomal spacer typing. In vitro macrophage cultures, murine experimental models and sand fly infections were used to evaluate infectivity in vitro and in vivo.
Results:
The isolate was identified as Leishmania (Viannia) braziliensis. In the atypical promastigotes grown in culture, a short flagellum surrounded or interrupted by a protuberance of disorganized material was observed. A normal axoneme was present close to the basal body but without elongation much further outside the flagellar pocket. A disorganized swelling at the precocious end of the axoneme coincided with the lack of a paraflagellar rod structure. The isolate was able to infect macrophages in vitro, induce lesions in BALB/c mice and infect Lutzomyia longipalpis.
Conclusions:
Notwithstanding the lack of an extracellular flagellum, this isolate infects macrophages in vitro and produces lesions when inoculated into mice. Moreover, it is able to colonize phlebotomine sand flies. Considering the importance attributed to the flagellum in the successful infection and survival of Leishmania in the insect midgut and in the invasion of macrophages, these findings may bring new light into the infectious mechanisms of L. (V.) braziliensis.</description>
        <link>http://www.parasitesandvectors.com/content/5/1/11</link>
                <dc:creator>Rogeria Zauli</dc:creator>
                <dc:creator>Jenicer Yokoyama-Yasunaka</dc:creator>
                <dc:creator>Danilo Miguel</dc:creator>
                <dc:creator>Alexandre Moura</dc:creator>
                <dc:creator>Ledice Pereira</dc:creator>
                <dc:creator>Ildefonso da Silva</dc:creator>
                <dc:creator>Lucianna Lemes</dc:creator>
                <dc:creator>Miriam Dorta</dc:creator>
                <dc:creator>Milton de Oliveira</dc:creator>
                <dc:creator>Andre Pitaluga</dc:creator>
                <dc:creator>Edna Ishikawa</dc:creator>
                <dc:creator>Juliany Rodrigues</dc:creator>
                <dc:creator>Yara Traub-Cseko</dc:creator>
                <dc:creator>A. Tania Bijovsky</dc:creator>
                <dc:creator>Fatima Ribeiro-Dias</dc:creator>
                <dc:creator>Silvia Uliana</dc:creator>
                <dc:source>Parasites &amp; Vectors 2012, null:11</dc:source>
        <dc:date>2012-01-11T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-3305-5-11</dc:identifier>
                                    <dc:description>We describe a morphologically atypical Leishmania isolate, obtained from a cutaneous leishmaniasis patient in Brazil. In axenic cultures, atypical promastigotes grow as round cells with very short or absent flagella. We  show that, in spite of the defective flagella, they can infect macrophages and are able to establish infections in mice and sand flies. Image: Atypical promastigote of a L. (V.) braziliensis isolate.</dc:description>
                <prism:require>/content/figures/1756-3305-5-11-toc.gif</prism:require>
                <prism:publicationName>Parasites &amp; Vectors</prism:publicationName>
        <prism:issn>1756-3305</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>11</prism:startingPage>
        <prism:publicationDate>2012-01-11T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.parasitesandvectors.com/content/4/1/234">
        <title>Neglected Tropical Diseases and the Millennium Development Goals - why the &quot;other diseases&quot; matter:  reality versus rhetoric</title>
        <description>Since 2004 there has been an increased recognition of the importance of Neglected Tropical Diseases (NTDs) as impediments to development. These diseases are caused by a variety of infectious agents - viruses, bacteria and parasites - which cause a diversity of clinical conditions throughout the tropics. The World Health Organisation (WHO) has defined seventeen of these conditions as core NTDs. The objectives for the control, elimination or eradication of these conditions have been defined in World Health Assembly resolutions whilst the strategies for the control or elimination of individual diseases have been defined in various WHO documents. Since 2005 there has been a drive for the expanded control of these diseases through an integrated approach of mass drug administration referred to as Preventive Chemotherapy via community-based distribution systems and through schools. This has been made possible by donations from major pharmaceutical companies of quality and efficacious drugs which have a proven track record of safety. As a result of the increased commitment of endemic countries, bilateral donors and non-governmental development organisations, there has been a considerable expansion of mass drug administration. In particular, programmes targeting lymphatic filariasis, onchocerciasis, schistosomiasis, trachoma and soil transmitted helminth infections have expanded to treat 887. 8 million people in 2009. There has been significant progress towards guinea worm eradication, and the control of leprosy and human African trypanosomiasis. This paper responds to what the authors believe are inappropriate criticisms of these programmes and counters accusations of the motives of partners made in recently published papers. We provide a detailed response and update the information on the numbers of global treatments undertaken for NTDs and list the success stories to date.The paper acknowledges that in undertaking any health programme in environments such as post-conflict countries, there are always challenges. It is also recognised that NTD control must always be undertaken within the health system context. However, it is important to emphasise that the availability of donated drugs, the multiple impact of those drugs, the willingness of countries to undertake their distribution, thereby committing their own resources to the programmes, and the proven beneficial results outweigh the problems which are faced in environments where communities are often beyond the reach of health services. Given the availability of these interventions, their cost effectiveness and the broader development impact we believe it would be unethical not to continue programmes of such long term benefit to the &quot;bottom billion&quot;.</description>
        <link>http://www.parasitesandvectors.com/content/4/1/234</link>
                <dc:creator>David Molyneux</dc:creator>
                <dc:creator>Mwele Malecela</dc:creator>
                <dc:source>Parasites &amp; Vectors 2011, null:234</dc:source>
        <dc:date>2011-12-13T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-3305-4-234</dc:identifier>
                            <dc:title>Mass drug distribution aids NTD eradication</dc:title>
                            <dc:description>The paper responds to criticism of mass drug distribution programmes for the control of neglected tropical diseases identifying recent successes and arguing for immediate expansion of programmes based on donated safe and efficacious drugs. Image: Drug distributor with dose pole in Zanzibar during mass distribution of praziquantel and albendazole (Courtesy WHO/A-F Gabrielli).</dc:description>
                <prism:require>/content/figures/1756-3305-4-234-toc.gif</prism:require>
                <prism:publicationName>Parasites &amp; Vectors</prism:publicationName>
        <prism:issn>1756-3305</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>234</prism:startingPage>
        <prism:publicationDate>2011-12-13T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.parasitesandvectors.com/content/5/1/9">
        <title>Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis</title>
        <description>Background:
Praziquantel (PZQ) is an isoquinoline derivative (2-cyclohexylcarbonyl-1, 2, 3, 6, 7, 11b-hexahydro-4H-pyrazino{2,1-a}-isoquinoline-4-one), and is currently the drug of choice for all forms of schistosomiasis. Silymarin, a standardized milk thistle extract, of which silibinin is the main component, is known for its hepatoprotective, anti-inflammatory, antioxidant activities, and hepatocyte regeneration. This study investigates the anti-inflammatory/anti-fibrotic effects of silymarin and/or PZQ on schistosomal hepatic fibrosis.
Methods:
Schistosoma mansoni-infected mice were divided into two large groups (I &amp; II), each with four subgroups and were run in parallel. (i) Infected untreated; (ii) treated with silymarin, starting from the 4th (3 weeks before PZQ therapy) or 12th (5 weeks after PZQ therapy) weeks post infection (PI); (iii) treated with PZQ in the 7th week PI; and (iv) treated with silymarin, as group (ii) plus PZQ as group (iii). Comparable groups of uninfected mice run in parallel with the infected groups. Mice of groups I and II were killed 10 and 18 weeks PI, respectively. Hepatic content of hydroxyproline (HYP), serum levels and tissue expression of matrix metalloproteinase-2 (MMP-2), transforming growth factor-B1 (TGF-B1) and number of mast cells were determined. In addition, parasitological, biochemical and histological parameters that reflect disease severity and morbidity were examined.
Results:
Silymarin caused a partial decrease in worm burden; hepatic tissue egg load, with an increase in percentage of dead eggs; modulation of granuloma size, with significant reduction of hepatic HYP content; tissue expression of MMP-2, TGF-B1; number of mast cells, with conservation of hepatic reduced glutathione (GSH). PZQ produced complete eradication of worms, eggs and alleviated liver inflammation and fibrosis. The best results were obtained, in most parameters studied, in groups of mice treated with silymarin in addition to PZQ.
Conclusions:
Our results point to silymarin as a promising anti-inflammatory and anti-fibrotic agent; it could be introduced as a therapeutic tool with PZQ in the treatment of schistosomal liver fibrosis, but further studies on mechanisms of silymarin and PZQ in chronic liver diseases may shed light on developing therapeutic methods in clinical practice.</description>
        <link>http://www.parasitesandvectors.com/content/5/1/9</link>
                <dc:creator>Naglaa El-Lakkany</dc:creator>
                <dc:creator>Olfat Hamam</dc:creator>
                <dc:creator>Walaa El-Madawy</dc:creator>
                <dc:creator>Afkar Badawy</dc:creator>
                <dc:creator>Afaf Ain-Shoka</dc:creator>
                <dc:creator>Fatma Ebeid</dc:creator>
                <dc:source>Parasites &amp; Vectors 2012, null:9</dc:source>
        <dc:date>2012-01-11T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-3305-5-9</dc:identifier>
                                    <dc:description>This study points to silymarin as a promising anti-inflammatory and anti-fibrotic agent and it could be introduced as a therapeutic tool with praziquantel in the treatment of schistosomal liver fibrosis. Image: Immunostain for TGF-&amp;#946;1 antibody in livers of mice treated with PZQ plus silymarin showing weakly and scattered positively stained hepatocytes and granuloma cells compared to infected untreated control.</dc:description>
                <prism:require>/content/figures/1756-3305-5-9-toc.gif</prism:require>
                <prism:publicationName>Parasites &amp; Vectors</prism:publicationName>
        <prism:issn>1756-3305</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>9</prism:startingPage>
        <prism:publicationDate>2012-01-11T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>

